Search

Your search keyword '"Alrukn, Suhail Abdulla"' showing total 4 results
Start Over Author "Alrukn, Suhail Abdulla"
4 results on '"Alrukn, Suhail Abdulla"'

1. Stroke services in MENA: What is there and what is needed

Author

Aref, Hany, primary, El Nahas, Nevine, additional, Alrukn, Suhail Abdulla, additional, Khan, Maria, additional, Kesraoui, Selma, additional, Alnidawi, Firas, additional, Hokmabadi, Elyar Sadeghi, additional, Farhoudi, Mehdi, additional, Fairooz, Muataz, additional, Batayha, Waleed, additional, Salmeen, Athari, additional, Abdulrahman, Husen, additional, Belahsen, Mohammed Faouzi, additional, Al Hashmi, Amal M., additional, Akhtar, Naveed, additional, Al-Johani, Mohammed, additional, Seidi, Osheik Abu’Asha, additional, Jouhar, Anas, additional, Mhiri, Chokri, additional, Elbassiouny, Ahmed, additional, Shokri, Hossam, additional, and Roushdy, Tamer, additional

Published
2023
Full Text
View/download PDF

2. New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study

Author

Wasay, Mohammad, primary, Khan, Maria, additional, Rajput, Haris Majid, additional, Farooq, Salman, additional, Memon, Mohammed Ibrahim, additional, AlRukn, Suhail Abdulla, additional, Malik, Abdul, additional, Abd-Allah, Foad, additional, Shoaib, Raja Farhat, additional, Shahid, Rizwana, additional, Nishat, Sadia, additional, and Awan, Safia, additional

Published
2019
Full Text
View/download PDF

4. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy.

Author

Hashim H, Zeb-un-Nisa, Alrukn SA, and Al Madani AA

Subjects
Adult, Antipsychotic Agents administration & dosage, Disease Progression, Drug Resistance, Female, Humans, Neuroleptic Malignant Syndrome diagnosis, Neuroleptic Malignant Syndrome drug therapy, Treatment Failure, Electroconvulsive Therapy, Neuroleptic Malignant Syndrome therapy
Abstract

Neuroleptic malignant syndrome is considered as a rare but potentially fatal complication of neuroleptic medications e.g.,antipsychotics, sedatives and anti emetics. It is characterized by hyperthermia, muscle rigidity, an elevated creatine kinase level and autonomic instability. The syndrome often develops after the start of antipsychotic or a sudden increase in dosage of the neuroleptic medication or in states of dehydration. Treatment is mainly supportive and includes withdrawal of the neuroleptic medication and, possibly, administration of drugs such as dantrolene and bromocriptine. In rare cases where drugs treatment remains ineffective a trial of electroconvulsive therapy is being given. The case presented is a drug resistant case of Neuroleptic Malignant Syndrome where finally electroconvulsive therapy was effective.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results